Search

everythinglearnresearchcommunity

for

Search:↓

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

A patient developed a blister at the injection site after hepatitis C treatment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Skin ulcers from interferon may not depend on the amount given.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.